Absci Balance Sheet
NASDAQ: ABSIHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Absci financial position
At the end of fiscal 2025, Absci reported total assets of $216.3 million, up 1.3% from a year earlier against total liabilities of $26.8 million. Shareholders' equity stood at $189.4 million, or 87.6% of assets. The company held $20.0 million in cash and equivalents against $0 of debt, a net cash position of $20.0 million.
The current ratio (current assets divided by current liabilities) was 6.57, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.00.
Summary generated from market data by MetaCap's automated system. Methodology
Absci balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 20.02M | 41.21M | 72.36M | 59.95M | 252.57M | 69.87M |
| Short-Term Investments | 124.27M | 71.21M | — | — | 0 | — |
| Receivables | — | 0 | 2.19M | — | — | — |
| Total Current Assets | 149.57M | 133.83M | 120.58M | 186.86M | 273.08M | 73.23M |
| Property, Plant & Equipment | 20.86M | 29.17M | 41.33M | 52.72M | 52.11M | 8.91M |
| Goodwill | — | — | 0 | 21.34M | 21.34M | 0 |
| Intangible Assets | 41.51M | 44.88M | 48.25M | 51.62M | 54.99M | 0 |
| Long-Term Investments | 11.80M | — | — | — | — | — |
| Total Assets | 216.30M | 213.61M | 217.30M | 321.01M | 426.19M | 88.57M |
| Accounts Payable | 2.76M | 2.95M | 1.50M | 2.41M | 8.38M | 2.12M |
| Total Current Liabilities | 22.77M | 28.66M | 29.56M | 30.27M | 33.86M | 10.10M |
| Long-Term Debt | 0 | 1.26M | 4.66M | 7.98M | 1.12M | 4.14M |
| Total Liabilities | 26.85M | 34.48M | 41.12M | 46.59M | 60.09M | 21.56M |
| Shareholders' Equity | 189.45M | 179.13M | 176.18M | 274.41M | 366.11M | -89.43M |
| Retained Earnings | -624.78M | -509.60M | -406.50M | -295.93M | -191.03M | -90.06M |
| Total Debt | 0 | 1.26M | 4.66M | 7.98M | 1.12M | 4.14M |
| Net Cash (Debt) | 144.29M | 111.17M | 67.70M | 51.97M | 251.44M | 65.73M |
| Shares Outstanding | — | 115.36M | 93.09M | 92.41M | 92.65M | 17.89M |
This table shows 6 annual periods of Absci's balance sheet, from FY 2025 back to FY 2020, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ABSI's reporting calendar. What is a balance sheet?